Please check your internet connection and try again.
# Hyoscine butylbromide
## Overview
Hyoscine butylbromide is an anticholinergic medication that acts peripherally to reduce smooth muscle spasms and secretions. It is primarily used for gastrointestinal spasms.
## Primary Indications
* Relief of abdominal cramping and spasms associated with irritable bowel syndrome (IBS).
* Management of biliary and renal colic.
* Preoperative medication to reduce secretions.
* Used in palliative care to reduce secretions (e.g., oral and bronchial secretions).
## Adult Dosing
* **Oral:** 10 mg to 20 mg three to four times daily. Maximum dose typically not specified, but consider total anticholinergic burden.
* **IM/IV:** 20 mg every 4 to 6 hours as needed. Maximum dose typically not specified.
* **Palliative Care (Subcutaneous infusion):** Dosing is highly individualized and often initiated at 20 mg per 24 hours, titrating as needed based on clinical response and patient tolerance. May range up to 60-100 mg per 24 hours. Prescribing information varies; consult local protocol.
## Pediatric Dosing
* **Oral:** Limited data. Generally not recommended for children under 12 years unless specifically advised by a physician. Some sources suggest 5 mg two to three times daily for children 6-12 years.
* **IM/IV/SC:** Data in pediatric populations is scarce. Use with caution and close monitoring.
## Dose Adjustments
No specific dose adjustments are typically required for hepatic or renal impairment, as the drug has minimal systemic absorption and is metabolized in the liver. However, caution is advised in patients with severe hepatic or renal disease.
## Contraindications
* Myasthenia gravis.
* Narrow-angle glaucoma.
* Tachyarrhythmias.
* Prostatic hypertrophy with urinary retention.
* Ileus or toxic megacolon.
* Pyloric stenosis and achalasia.
* Hypersensitivity to hyoscine butylbromide or any component of the formulation.
## Adverse Effects
Common: Dry mouth, blurred vision, constipation, urinary retention, tachycardia, decreased sweating, drowsiness.
Less common: Dizziness, rash, urticaria.
## Key Drug Interactions
* **Other Anticholinergics (e.g., tricyclic antidepressants, antipsychotics, antihistamines):** Additive anticholinergic effects, increasing the risk of adverse effects like dry mouth, blurred vision, constipation, and urinary retention.
* **Dopamine antagonists (e.g., metoclopramide):** May reduce the efficacy of both drugs.
* **Medications with anticholinergic properties:** Increased risk of adverse effects.
## Monitoring
* Monitor for signs of anticholinergic adverse effects (dry mouth, blurred vision, urinary retention, constipation, tachycardia).
* Assess for pain relief and reduction in spasms.
* In palliative care, monitor for effectiveness in reducing secretions and for adverse effects.
## Clinical Pearls
* Hyoscine butylbromide primarily acts locally in the gastrointestinal tract, leading to fewer systemic anticholinergic effects compared to scopolamine (hyoscine hydrobromide).
* Intramuscular or intravenous administration provides faster relief for acute colic.
* In palliative care, it can be administered subcutaneously via infusion for continuous symptom management.
* Ensure adequate hydration and consider stool softeners to manage potential constipation.
---
*Disclaimer: This information is intended for healthcare professionals. Always consult the most current prescribing information and local protocols before making clinical decisions.*
